Lenalidomide and risk of second primary malignancy-is disease context key?

Lancet Haematol

The Institute of Cancer Research, London SM2 5NG, UK; The Royal Marsden Hospital NHS Foundation Trust, London, UK.

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(22)00334-9DOI Listing

Publication Analysis

Top Keywords

lenalidomide risk
4
risk second
4
second primary
4
primary malignancy-is
4
malignancy-is disease
4
disease context
4
context key?
4
lenalidomide
1
second
1
primary
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!